Full View

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - Am Heart Assoc
Background—Angiotensin-converting enzyme (ACE) inhibitors have been shown to
attenuate left ventricular (LV) enlargement in association with reducing mortality after …
被引用次数：370 相关文章

[引用][C] Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD SOLOMON, H SKALI… - … (New York, NY), 2005 - pascal-francis.inist.fr
Changes in ventricular size and function in patients treated with valsartan, captopril, or both
after myocardial infarction CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - elibrary.ru

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - 2005 - pubmed.ncbi.nlm.nih.gov
Background Angiotensin-converting enzyme (ACE) inhibitors have been shown to attenuate
left ventricular (LV) enlargement in association with reducing mortality after myocardial …

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - europepmc.org
Background Angiotensin-converting enzyme (ACE) inhibitors have been shown to attenuate
left ventricular (LV) enlargement in association with reducing mortality after myocardial …

[引用][C] Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - eprints.gla.ac.uk
Changes in ventricular size and function in patients treated with valsartan, captopril, or both
after myocardial infarction - Enlighten Publications Skip to main content Accessibility …
[PDF] psu.edu

[PDF][PDF] Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - 2005 - Citeseer
Background—Angiotensin-converting enzyme (ACE) inhibitors have been shown to
attenuate left ventricular (LV) enlargement in association with reducing mortality after …

Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction

SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - cir.nii.ac.jp
< jats: p>< jats: bold>< jats: italic> Background—</jats: italic></jats: bold> Angiotensin-
converting enzyme (ACE) inhibitors have been shown to attenuate left ventricular (LV) …

[引用][C] Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

S SD - Circulation, 2005 - cir.nii.ac.jp
Changes in ventricular size and function in patients treated with valsartan, captopril, or both
after myocardial infarction | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[引用][C] Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

SD SOLOMON, H SKALI, NS ANAVEKAR… - …, 2005 - Lippincott Williams & Wilkins